Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

629
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
629
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.5K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.5K
Amyloid Fibrils03:03

Amyloid Fibrils

5.7K
5.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

5.7K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

457
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
457
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.

Nature metabolism·2026
Same author

What is the role of amylin as an emerging therapeutic agent in obesity?

Expert review of endocrinology & metabolism·2026
Same author

Amylin analogues as a novel perspective in anti-obesity therapy.

British journal of pharmacology·2026
Same author

Amylin.

Trends in endocrinology and metabolism: TEM·2026
Same author

The story of amylin: from physiology to therapy.

Nature metabolism·2026
Same author

Evaluation of Pancreatic Endocrine Reprogramming in Diabetic Cats.

Veterinary sciences·2025

Related Experiment Video

Updated: Oct 3, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.4K

Creating the amylin story.

Thomas A Lutz1

  • 1Institute of Veterinary Physiology Vetsuisse Faculty University of Zurich Winterthurerstrasse, 260 8057, Zurich, Switzerland.

Appetite
|February 20, 2022
PubMed
Summary
This summary is machine-generated.

Amylin, a pancreatic hormone, is implicated in type 2 diabetes and obesity. Research into its role has led to promising anti-obesity drug development.

Keywords:
AdiposityAmylinCTRCagrilintideIslet amyloid polypeptide (IAPP)LeptinRAMPRewardSatiation

More Related Videos

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K

Related Experiment Videos

Last Updated: Oct 3, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.4K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Diabetes Pathophysiology

Background:

  • Amylin is a key component of pancreatic islet amyloid deposits, prevalent in type 2 diabetes.
  • These deposits, particularly amylin oligomers, are linked to progressive beta-cell destruction in type 2 diabetes.
  • Amylin functions as a circulating hormone influencing appetite, glucagon secretion, and gastric emptying.

Purpose of the Study:

  • To provide a personal overview of key discoveries concerning amylin.
  • To highlight amylin's dual role as an islet amyloid component and a metabolic hormone.
  • To discuss the implications of amylin research for therapeutic development.

Main Methods:

  • Review of historical research and personal insights into amylin discovery.
  • Synthesis of existing literature on amylin's physiological and pathophysiological roles.
  • Discussion of amylin's mechanism of action and therapeutic potential.

Main Results:

  • Amylin's discovery as the primary constituent of pancreatic islet amyloid.
  • Identification of amylin's significant metabolic functions, including appetite regulation.
  • Evidence linking amylin aggregates to beta-cell dysfunction in type 2 diabetes.

Conclusions:

  • Amylin research has significantly advanced our understanding of type 2 diabetes and metabolic regulation.
  • Amylin analogues represent a promising therapeutic strategy for obesity treatment.
  • Continued investigation into amylin's multifaceted roles is crucial for future advancements.